We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $17.37, moving -1.19% from the previous trading session. This change lagged the S&P 500's 0.76% loss on the day. Meanwhile, the Dow lost 0.75%, and the Nasdaq, a tech-heavy index, lost 1.01%.
Shares of the company witnessed a loss of 19.8% over the previous month, trailing the performance of the Finance sector with its loss of 3.43% and the S&P 500's gain of 4.31%.
The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on November 7, 2024. The company is predicted to post an EPS of -$0.20, indicating a 31.03% growth compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $2.32 billion, indicating a 61.39% increase compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.01 per share and revenue of $9.04 billion. These totals would mark changes of +100.82% and +54.2%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Oscar Health, Inc. has a Forward P/E ratio of 1318.5 right now. This valuation marks a premium compared to its industry's average Forward P/E of 10.65.
One should further note that OSCR currently holds a PEG ratio of 34.83. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Insurance - Multi line industry had an average PEG ratio of 1.23 as trading concluded yesterday.
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 99, positioning it in the top 40% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $17.37, moving -1.19% from the previous trading session. This change lagged the S&P 500's 0.76% loss on the day. Meanwhile, the Dow lost 0.75%, and the Nasdaq, a tech-heavy index, lost 1.01%.
Shares of the company witnessed a loss of 19.8% over the previous month, trailing the performance of the Finance sector with its loss of 3.43% and the S&P 500's gain of 4.31%.
The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on November 7, 2024. The company is predicted to post an EPS of -$0.20, indicating a 31.03% growth compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $2.32 billion, indicating a 61.39% increase compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.01 per share and revenue of $9.04 billion. These totals would mark changes of +100.82% and +54.2%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Oscar Health, Inc. has a Forward P/E ratio of 1318.5 right now. This valuation marks a premium compared to its industry's average Forward P/E of 10.65.
One should further note that OSCR currently holds a PEG ratio of 34.83. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Insurance - Multi line industry had an average PEG ratio of 1.23 as trading concluded yesterday.
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 99, positioning it in the top 40% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.